New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

Prime Medicine has been given ... taken from CGD patients outside the body, to edit out a mutation in the gene coding for the NADPH oxidase complex that prevents phagocytic cells of the immune ...

Since the technique was first published in 2019, prime editing has grown with lightning speed, alongside hopes for what it can achieve. Emilie is an assistant editor at the Scientist. She has a ...

First used in 2019, prime editing, also known as "search-and-replace" editing, is a genome editing tool to search for a section in the genome (the entire set of DNA), make a nick and then replace ...

GenScript has signed a licensing agreement with the Broad Institute of MIT to access Broad's Prime Editing technology. GenScript USA Inc. is the world’s leading life-science research tools and ...

On Tuesday, Prime Medicine announced it was developing a gene-editing treatment for a debilitating lung and liver disorder called alpha-1-antitrypsin deficiency. On the surface, it’s an ...

(RTTNews) - Prime Medicine, Inc.(PRME), Tuesday announced the initiation of its preclinical program for the treatment of Alpha-1 Antitrypsin Deficiency or AATD using its proprietary Prime Editing ...

We look forward to progressing our AATD and Wilson’s Disease programs toward clinical data in 2027, where we hope to demonstrate Prime Editing’s best-in-class potential across two of the ...

GenScript has signed a licensing agreement with the Broad Institute of MIT to access Broad's Prime Editing technology. "This partnership with the Broad Institute marks an exhilarating new ...